Jacob White is a journalist whose work has appeared in publications such as FantasyPros and Gridiron Experts. He specializes in covering news and developments in the biopharmaceutical industry, including mergers and acquisitions, manufacturing updates, and partnering news. Jacob provides in-depth analysis and reporting on the latest happenings in the pharmaceutical world.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Jacob White's articles primarily focus on press releases and private sector announcements related to the healthcare and pharmaceutical industry, with an emphasis on mergers and acquisitions. He frequently covers news about specific companies in the pharmaceutical industry, including their partnerships, manufacturing updates, and supplier relationships.
Given this focus, Jacob is likely to be interested in receiving pitches related to breaking news about mergers and acquisitions within the pharmaceutical industry or significant partnerships between major healthcare companies. Additionally, he may be open to receiving information about new developments from key suppliers or manufacturers within the sector.
Pitches should provide concise details of how a particular announcement or development contributes to broader trends within the healthcare and pharmaceutical landscape.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Jacob White
Merck & Co. and LaNova Medicines, a Shanghai-based bio/pharmaceutical company, have entered into an exclusive global license to develop, manufacture and commercialize LaNova Medicine's LM-299, an investigational bispecific antibody from LaNova, in a deal worth up to $3.3 billion ($588 million upfront and $2.7 billion in milestone payments).
Supplier News: Lonza, Adragos, Avantor & More The latest from CDMOs, CMOs, and suppliers featuring Lonza, Avantor, Adragos Pharma, Gilero, Sekisui Cryoport and GenScript Biotech.
By: Jacob White
Otsuka Pharmaceutical Factory (OPF), a subsidiary of Otsuka Holdings, and ICU Medical, a medical device company, have formed a joint venture (JV) for IV solutions to serve the North American market.
Partnering News: Roche, Novo Nordisk, Ascendis & More A roundup of bio/pharmaceutical partnering news from Roche/Flare Therapeutics, Novo Nordisk/Ascendis Pharma and Royalty Pharma/Syndax.
Amcor, a Zurich, Switzerland-based provider of packaging for the pharmaceutical, food, beverage, and other markets, has agreed to acquire Berry Global, an Evansville, Indiana-based provider of packaging for various markets, including pharmaceuticals, in an $8.4-billion deal.
Novartis has acquired Kate Therapeutics, a San Diego, California-based gene-therapy company for treating genetically defined neuromuscular diseases, in a $1.1-billion deal (undisclosed upfront payment and additional milestone payments)
Mfg News: Sanofi, Orano Med & Endo A roundup of manufacturing news from Sanofi, Orano Med, and Endo. Highlights below
By: Jacob White
Grifols, a Barcelona, Spain-headquarted healthcare company and manufacturer of plasma-derived medicines, has turned a potential offer of EUR 6.45 billion ($6.76 billion) by Brookfield, a Toronto, Canada-based private equity firm.
Supplier News: Samsung Biologic, Fujifilm Diosynth, Evotec & More The latest from CDMOs, CMOs, and suppliers featuring Samsung Biologics, Fujifilm Diosynth Biotechnologies, Vetter, Pii, and Evotec.
Global Briefs: Pfizer, Amgen & Novartis A roundup of news from Pfizer, Amgen, and Novartis. Highlights below. Appointments
(833) 317-6278 
